Screen Reader Mode Icon

International survey of Neurorehabilitation and how it has been affected by COVID-19

Task Force Members
Izumi Kondo, Japan (Chair)
Marta Imamura (Brazil)
Sabahat Wasti (United Arab Emirates)
Caterina Pistarini (Italy)
 
1. The main objective of this survey is to learn about the experience of neurorehabilitation professionals who provide neurorehabilitation to victims of COVID-19 with neurological complications. The survey is not limited to the professionals who directly treat patients with Corona virus infection.
 
2. This survey addresses following three important issues:
1) The experience of management of neurological manifestations of Corona virus infection, either directly caused by it or acquired due to complications of its treatment such as peroneal nerve palsy following prolonged bed confinement.
2) The effect on the rehabilitation of patients who suffer from usual neurological diseases such as stroke, spinal cord injury or brain injury due to redeployment of medical resources during rapid spread of pandemic.
3) Neuropsychological impact of COVID-19 infection on patients and stress related effects on neurorehabilitation professionals

Question Title

* 1. What discipline you belong to?

Question Title

* 3. Have you been or are you involved in treating COVID-19 Patients?

Question Title

* 4. Approximately how many COVID-19 patients have you been involved with per month?

Question Title

* 5. Approximately how long have you worked/ are you working with COVID-19 patients?

Question Title

* 6. Is there a formal COVID-19 education for neurorehabilitation staff in your region?

Question Title

* 7. If No, did you educate yourself about COVID-19 prior to providing treatment to COVID-19 patients?

Question Title

* 8. At the phase of emergency or contaminating phase, does status of patients influence decisions for their taking charge by rehabilitation team?

Question Title

* 9. At the phase of emergency or contaminating phase, Does COVID-19 status of patients cause first contacts to be delayed?

Question Title

* 10. If Yes for Q9, by:

Question Title

* 11. If there are delays in assessing patients is this due to:

Question Title

* 12. Where there is a delay in assessing patients due to their clinical condition, does it occur regardless of their COVID-19 status?

Question Title

* 13. In patients without COVID-19 who need isolation to protect them from COVID-19, for example patients with spinal cord injury, does the isolation status of these patients interfere with treatments and interventions?

Question Title

* 14. If Yes for Q13

Question Title

* 15. Do PPEs interfere with therapies and interventions?

Question Title

* 16. Do COVID-19 status of patients have an impact on their potential outcomes?

Question Title

* 17. If Yes for Q16, at when does it occur?

Question Title

* 18. What COVID-19 complications have you addressed in your rehabilitation practice? Please, select all that apply.

Question Title

* 19. Main rehabilitation interventions prescribed: Please, select all that apply.

Question Title

* 20. Has your country established a neurorehabilitation national plan prior to COVID-19 pandemic?

Question Title

* 21. How are neurorehabilitation services usually provided in your country?  Please select all that apply.

Question Title

* 22. Has COVID-19 had an impact on inpatient Neurorehabilitation Service in your region?

Question Title

* 23. If Yes for Q22: Has your work increased ?

Question Title

* 24. If Yes for Q23: Was it due to increased number of COVID-19 patients with neurological complications?

Question Title

* 25. If Yes for Q24: What manifestations / complications are seen most:

Question Title

* 26. Has your work decreased ?

Question Title

* 27. If Yes for Q26: Is it due to: Resources have been re-allocated to acute care

Question Title

* 28. Have the staff been redeployed to to acute care

Question Title

* 29. Has closure of service occurred ?

Question Title

* 30. If Yes for Q29: Reason given to you by management for reducing / stopping the service

Question Title

* 31. Has there been an impact on outpatient neurorehabilitation service due to COVID-19 ?

Question Title

* 32. Has it become less busy ?

Question Title

* 33. If Yes for Q32: Patients want to come but cannot due to restrictions

Question Title

* 34. If Yes for Q32: Are patient reluctant / unwilling to attend because of fear of contracting COVID-19

Question Title

* 35. If Yes for Q32: Has the staff been redeployed

Question Title

* 36. Is the COVID-19 testing delaying patient’s attendance

Question Title

* 37. Has there been a shift to Tele / digital visits?

Question Title

* 38. Based on experience so far please give 2 positives and 2 negatives of Tele / digital visits

Question Title

* 39. Has COVID-19 had an impact on Community Based Neurorehabilitation in your area ?

Question Title

* 40. If Yes for Q39: Is it due to: Local regulations restricting visits?

Question Title

* 41. If Yes for Q39: Is it due to reluctance of patients and their families to allow visits by neurorehabilitation staff?

Question Title

* 42. If Yes for Q39: Is it due to reluctance of staff to go out on visits?

Question Title

* 43. If Yes for Q39: Is it due to cost and / or availability of PPEs?

Question Title

* 44. If Yes for Q39: Is it due to difficulty with transportation due to lock down?

Question Title

* 45. If No for Q39: is it due to special arrangements that have been made in your region

Question Title

* 46. If Yes for Q45: Please state what special arrangements were made

Question Title

* 47. Do You think the vaccination campaign has been duly enhanced in your country?

Question Title

* 48. Has your country already started the vaccination of health professionals delivering neurorehabilitation?

Question Title

* 49. Has your country already started the vaccination of patients requiring neurorehabilitation?

Question Title

* 50. Please state if you have any other comments on the subject of Neurorehabilitation in COVID-19.

0/50回答済み
 

T